/

Workspace

Research & Review

Writing & Publishing

Data & Analysis

Utilities

Account

User Settings

F

Filippo de Marinis

Istituto Oncologico Veneto(IT)

Claim or correct this author profile

Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.

725

Papers

46.1K

Citations

79

h-index

313

i10-index

Filippo de Marinis is an academic researcher from Istituto Oncologico Veneto. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Lung Cancer Research Studies & Lung Cancer Diagnosis and Treatment. The author has an h-index of 79, co-authored 617 publications.

ORCID: 0000-0002-1118-5536

Research Topics

Lung Cancer Treatments and Mutations Lung Cancer Research Studies Lung Cancer Diagnosis and Treatment Colorectal Cancer Treatments and Studies Cancer Immunotherapy and Biomarkers

Papers by this author

works

Natural History of Non-Small-Cell Lung Cancer with Bone Metastases

2015 · Scientific Reports · 136 citations

https://doi.org/10.1038/srep18670

Daniele Santini Sandro Barni Salvatore Intagliata Alfredo Falcone

Gefitinib as first-line treatment for patients with advanced non-small-cell lung cancer with activating epidermal growth factor receptor mutation: Review of the evidence

2011 · Lung Cancer · 130 citations

https://doi.org/10.1016/j.lungcan.2010.12.008

Cesare Gridelli Filippo de Marinis Massimo Di Maïo Diego Cortinovis

Positron Emission Tomography (PET) radiotracers in oncology – utility of 18F-Fluoro-deoxy-glucose (FDG)-PET in the management of patients with non-small-cell lung cancer (NSCLC)

2008 · Journal of Experimental & Clinical Cancer Research · 76 citations

https://doi.org/10.1186/1756-9966-27-52

Evelina Miele Gian Paolo Spinelli Federica Tomao Angelo Zullo

Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology

2009 · Lung Cancer · 70 citations

https://doi.org/10.1016/j.lungcan.2009.11.018

Cesare Gridelli Andrea Ardizzoni Jean‐Yves Douillard Nasser H. Hanna

First-line immunotherapy in advanced non-small-cell lung cancer patients with ECOG performance status 2: results of an International Expert Panel Meeting by the Italian Association of Thoracic Oncology

2021 · ESMO Open · 40 citations

https://doi.org/10.1016/j.esmoop.2021.100355

Cesare Gridelli Solange Peters Tony Mok Patrick M. Forde

Long-Term and Low-Grade Safety Results of a Phase III Study (PARAMOUNT): Maintenance Pemetrexed Plus Best Supportive Care Versus Placebo Plus Best Supportive Care Immediately After Induction Treatment With Pemetrexed Plus Cisplatin for Advanced Nonsquamous Non–Small-Cell Lung Cancer

2014 · Clinical Lung Cancer · 36 citations

https://doi.org/10.1016/j.cllc.2014.06.007

Jean-Louis Pujol Luis Paz‐Ares Filippo de Marinis Mircea Dediu

Research topics

topics

Lung Cancer Treatments and Mutations

Lung Cancer Research Studies

Lung Cancer Diagnosis and Treatment

Colorectal Cancer Treatments and Studies

Cancer Immunotherapy and Biomarkers

Chat about Author

Papers

Chat

Click to start Chat